Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Summary of Shareholder Webcast Questions - to date (taken from your posts)

Summary of Shareholder Webcast Questions - to date (taken from your posts)

posted on Apr 06, 2009 07:08AM

PTSC Shareholder Webcast: April 14th, 2009 … 4:30 p.m. EST

Shareholder Questions:

1 MMP: - valid or rejected?

2. Moore vs. TPL: - threat or non-event?

3. Crossflo: - profitable or not profitable in fiscal year 2009?

4. Holocom, Talis, Avot: - next steps?

5. M & A: - Are plans for M & A activities on hold, due to lack of money?

6. Stock Repurchase Plan: - stopped?

7. Avot: - Are we planning on investing more into Avot?

8. Nupower: - Who is licensing their technology? TPL? In-house? Newpower/PTSC combo?

9. TPL Expenses: - Is management confident that expenses billed by TPL Ventures is not connected to licensing?

Share
New Message
Please login to post a reply